We conducted a retrospective study of 104 cases of salivary gland tumors that were initially assessed byfi neneedle aspiration biopsy (FNA B). Based on subsequent histop athologic analysis ofexcised specimens, we found that preoperative FNAB was highly sensitive and specific f or both benign and malignant tumo rs-including the most common, pleom orphic adenomas and squamo us cell carcin omas , resp ectively. Despite its possibl e dra wbacks, we conclude that preop erative FNAB is a useful tool in the mana gement of salivary gland tum ors.
Introduction
Salivary gland neopl asms account for fewe r than 2% of all human neoplasms. I When they do occur, most arise in the parotid gland; a small percentage occur in the submandibular, sublingual, and minor salivary glands. There is a wide variety of histologic types of salivary gland tumors , both benign and malignant.
The management of salivary gland tumors is based on clinical assessment, radiologic investig ation , and cytologic study of fine -needle aspiration biop sy (FNAB) specimens. Concerns about the safety of FNAB include bleeding, tumor seeding, and facial nerve injury. Nevertheless, various studies over the past decade have found that FNAB is an accurate and useful investigation." !"
In this article, we describe our study of the accuracy of FNAB cytology in patients with salivary gland tumors at our institution. We also discuss the findings of other researche rs who have studied this topic .
Patients and methods
We retrospectively reviewed the medical recor ds of 104 patients who had undergone FNAB biopsy and subse-quent surgery for a salivary gland tumor at our institution between Oct. 1, 1996, and Dec . 31, 2002. FNAB had been performed at several different centers, surg ery had been performed by 1 of 2 surgeons in the Head and Neck unit of our institution, and histolog ic analysis of the surgical specimens had been performed by several different pathologi sts at our institution. Preoperative cytology result s were classified as either benign, mali gnant, or nondiagnostic. In most cases of benign or malign ant disease, the cytolo gist suggested a diagnosis , which was also recorded .
We comp ared the histopathology of the surgical specimens with the preoperative cytology of the FNAB specimens and calcul ated the sensitivity, spec ificity, positive predi ctive value (PPV), negative predicti ve value (NPV), and overall accuracy of FNAB for diagnosing benign and malignant disease. We also calculated FNAB 's ability to identify the most common histopathologies in both categories . Our study protocol was approved by the Human Research Ethic s Committee of Northern Sydney Health.
Results
Of the 104 FNAB s, 64 (6 1.5%) were originally classified as benign, 30 (28.8%) as malignant, and 10 (9.6%) as nondi agnostic. Histop athology of the exc ised specimens revealed that 70 patients (67.3%) had benign disease and 34 (32.7%) had mali gnant disease (table 1) .
Benign disease. FNAB correctl y identified 62 of 70 benign lesions (sensitivity: 88.6%) (table 2). Of the eight false-n egativ e results (table 3) , seven were actually nondi agnostic rather than malignant. Therefore , when the nondi agnostic results were excluded from the analysis, the sensitivity of FNAB for benign disease was 98.4%. The specificity of FNAB for benign disease was 94. 1% overall and 93.5% when nond iagnostic results were exclud ed (there were two false positives [table 3]). The PPV for benign disease was 0.969, and the NPV was 0.80. Therefore, the overall accuracy of FNAB for benign disease was 90.4 % (table 2) . been reported to range from 90 to 100%; our rate was 98.6%.
In another study from Australia , Que Hee and Perry concluded that FNAB is unreliable .'! They analyzed the diagnostic acc uracy of FNAB in 169 patients at a city teaching hospital similar to our ow n institution. They found that the specificity of FNAB for malignant disease overa ll and for see was 100 and 99%, respectivelyrates that are similar to our own (98.6 and 100%). However, they also reported a markedly lower sensitivity for malignant disease (57%) and for see (52%); our rates The most commo n benig n disease in this study was pleomorphic adeno ma. In diagnosi ng this tumor, FNA B had a sensitivi ty of 88.2%, a specificity of 98.1%, and an overa ll acc uracy of 93.3 % (table 2) .
Malignant disease. The overall sensitivity of FNAB for detecting malignant disease in general was 85.3%. Of the five false-negative results (table 3) , three were actually nondi agnostic rather than benign. Therefore, when the nond iagnostic results were excluded, the sensitivity of FNAB for malignant disease was 93.5%. The specifici ty of FNAB for malignant disease was 98.6 % overall and 98.4 % when the nondiagnostic results were excl uded (there was one false positive [table 3]). The PPV was 0.967, the NPV was 0.932, and the overall accuracy was 94.2% (table 2) .
Squamous cell carcinoma (Se C) was the most common malignant pathology. The sensitivity of FNAB was 88.9%, its specificity was 100%, and its overa ll acc uracy was 98.0% (table 2) .
Overall. For benign and malig nant tumors comb ined, sensitivity, specificity, and accurac y were 86.9, 96.3, and 92.3%, respec tively (table 2) .
Discussion
The sensitivity and spec ificity of FNAB for benign and malignant disease in our study were comp arabl e to or better than previously reported rates." !"
The overall accuracy of cytologic diagnosis based on FNAB has been reporte d to range from 56 to 98 %; our overall accur acy rate was 92.3%. For benign lesions, the reported sensitivity of FNAB ranges from 76 to 97%; our rate was 88.6%. The specificity of FNAB has been reported to range from 6 1 to 83%; our rate was 94.1%.
For malignant lesions, reported rates of sensitivity range from 55 to 87%; our rate was 85.3%. Specificity has Table 3 . False negatives and false positives for benign and malignant disease were 85,3 and 88.9%, res pectively. Wit h res pec t to benign disease, they re por ted a comparable sensitivity (88 vs. 88.6%) but a much lower specificity (6 1 vs. 94 .1%). Also, they found that FNA B had a lower sensitivity for ple om orphic adenoma (78 vs. 88.2 %), but a similar specificity (95 vs. 98 .1%). Que Hee and Perry based their co nclusion that FNAB is unreli able on the low sensitivity for malignant disease. When FNAB is nondiagnostic-which occurred in 9.6% of our cases-some auth ors reco mme nd per forming an ultrasound-guided co re biopsy to obtain a tissue diagnosis." However , it is our usual prac tice in such cases to per form a repeat FNAB. In our study, the sensitivity of FNAB for beni gn and malignant disease improved substa ntia lly when nond iagnostic find ings were excluded, while its spec ific ity remained abo ut the same. It is important to acknow ledge that a nondiag nos tic res ult is not a nega tive res ult; rat her, it represents an inva lid test.
Some of the fa lse-nega tive and false-positive res ults in our study deserve me ntio n. Firs t, two of the five specimens that were falsely negative for ma lignancy were lymphomas. Th ese were the only cases of lymphom a in our gro up of patients. Th e fact that both were not detected as malignant on FN AB is co nsis tent with other reports that lymph om a is diffi cul t to diagnose by FN AB .4-6·13If a lymph oma is suspected on clinical gro unds, flow cytometry of FNAB ca n be a useful diagnostic aid."
Second , the only false positiv e for malignancy in our study was repo rted as "large malignant ce lls suggesting carcinoma" on cytology. Th is tumor was later found to be a pleom orph ic ade no ma on histopathology. Con versely, a fin ding of pleomorphic adenoma on FNAB does not co mp letely exclude the presence of an ade nocarcinoma on histology. In rare cases, adenocarcino ma arises in a pre -ex isting pleomorphic adenoma, such as occurred in one of our pati ent s. Such a tum or may not be detected because of a sampling error or an incorrect cytologic interpretation ." The grea t variety of histol ogic appea rances of salivary gland tum ors does make cytolo gic diagn osis a challenging and often difficult proc ess. It is imp ort ant that the pathologist be familiar with the atypical features of some tumors."
Th ere are other concerns about the use of FNAB pre op erativ ely. Some authors have suggested that FNAB can ca use histologic cha nges that can obscure a histologic diagnosis." :" However, the findings of at lea st one large study appea r to disprove this idea. 17 Mukunyadzi et al found that while FNAB may produ ce cha nges such as infarctio n and hemorrhage, these changes were usually not extensive enoug h to compromi se a histologic diagnosis. ' ? We did not use adj unctive techni ques to imp rove the diagnostic acc uracy of FNA B in our study, but so me have been show n to be help ful. Megerian and Mani gli a report ed that preoper ative FNA B combined with intrao pera tive froze n-sec tion ana lysis result ed in a high er rate of diagnostic accuracy than either procedure alone.IS Lik ewise, Takashim a et al suggested that a combination of clinical assessme nt, magnetic reson ance imaging, and FNAB with cytology and flow cytometry improves accuracy."
We beli eve that FNAB is useful in preop erative plannin g for several reasons. As already discu ssed , lymphoma can be diagnosed by flo w cytometry of an FNAB specimen . Appropriate chem oth erapy ca n then be administered and surg ery av oided. Ou r study has also show n that FNAB was highl y acc ura te at diagnosin g SCC, the most co mmo n malign ant sa liva ry gland neoplasm in Au stralia. Making this diagn osis preoperatively allows for tum or exc ision and neck dissection to be performed in one operation when this is deem ed beneficial. Likewise, a diagn osis of mel anom a may allow neck dissecti on to be performed during the sa me operation as the tum or exc isio n. Alterna tely, if W arthin' s tumor is diagnosed in a patient deemed to be a high surgical risk , a non surgical approach with regul ar follow-up ca n be taken.
In conclusion, we found that FNAB is an acc urate mean s of diagnosin g both beni gn and malign ant salivary gland tum ors at our institutio n. It is es pec ially useful in excl udi ng SCC Although it is import ant to be mindful of the possible pitfall s of FNAB, we beli eve it plays a useful role in the assessment of salivary gland tumors. For more information on the CME program contact:
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